Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. [electronic resource]
Producer: 20090715Description: 3148-53 p. digitalISSN:- 1527-7755
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Bayes Theorem
- Benzamides
- Disease-Free Survival
- Female
- Humans
- Imatinib Mesylate
- Immunohistochemistry
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Polymerase Chain Reaction
- Pyrimidines -- therapeutic use
- Sarcoma -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.